Martin Feuchtenberger

Author

University of Würzburg ORCID

Also Known As

Hans-Peter Tony, M Feuchtenberger, M. Feuchtenberger, Martin Feuchtenberger, Stefan Kleinert

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

University of Würzburg Medias Klinikum Heidelberg University Charité - Universitätsmedizin Berlin University of Tübingen

About

Martin Feuchtenberger is an author at University of Würzburg specializing in rheumatoid arthritis, rheumatic diseases, and rheumatology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	394
2	Epidemiology	2	2	98
3	Public Health	1	1	46
4	Hepatology	1	1	15
5	Immunology	1	1	15

Martin Feuchtenberger

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Relapse rates in patients with rheumatoid arthritis in stable remission tapering or stopping antirheumatic therapy: interim results from the prospective randomised controlled RETRO study Judith Haschka, Matthias Englbrecht, Axel J. Hueber, Annals of the Rheumatic Diseases	2015	189
Continuing versus tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis (SEMIRA): a double-blind, multicentre, randomised controlled trial Gerd R Burmester, Frank Buttgereit, Corrado Bernasconi, The Lancet Rheumatoid DisorderRheumatologyLow Disease ActivityAutoimmune DiseaseRheumatic Diseases	2020	121
Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial Jürgen Rech, Koray Taşçılar, Melanie Hagen, The Lancet InflammationRheumatologyRheumatoid DisorderAnti-inflammatoryAutoimmune Disease	2024	118
Prediction of disease relapses by multibiomarker disease activity and autoantibody status in patients with rheumatoid arthritis on tapering DMARD treatment Jürgen Rech, Axel J. Hueber, Stephanie Finzel, Annals of the Rheumatic Diseases	2015	89
Intestinal B cells license metabolic T-cell activation in NASH microbiota/antigen-independently and contribute to fibrosis by IgA-FcR signalling Elena Kotsiliti, Valentina Leone, Svenja Schuehle, Journal of Hepatology	2023	85
Screening for latent tuberculosis infection: performance of tuberculin skin test and interferon-γ release assays under real-life conditions Stefan Kleinert, H-P Tony, Klaus Krueger, Annals of the Rheumatic Diseases	2012	71
Micronodular thymoma: an epithelial tumour with abnormal chemokine expression setting the stage for lymphoma development Philipp Ströbel, Mirella Marino, Martin Feuchtenberger, The Journal of Pathology	2005	58
Antimodified protein antibody response pattern influences the risk for disease relapse in patients with rheumatoid arthritis tapering disease modifying antirheumatic drugs Camille P. Figueiredo, Holger Bang, Jayme Fogagnolo Cobra, Annals of the Rheumatic Diseases	2016	55
Impact of patient and disease characteristics on therapeutic success during adalimumab treatment of patients with rheumatoid arthritis: data from a German noninterventional observational study Stefan Kleinert, Hans‐Peter Tony, Andreas Krause, Rheumatology International Rheumatoid DisorderRheumatologyDisease CharacteristicsEpidemiologyRheumatic Diseases	2011	52
Vaccination survey in patients with rheumatoid arthritis: a cross-sectional study Martin Feuchtenberger, Stefan Kleinert, Sven Schwab, Rheumatology International VaccinationRheumatologyRheumatoid DisorderEpidemiologyPreventive Medicine	2011	46

Page 1